David J. Wambeke, CBO at Diamedica Therapeutics, holds 1.00M shares in NeuroOne Medical Technologies (Ticker: NMTC), holds 527.11K shares in Diamedica Therapeutics (Ticker: DMAC). Most recently, David J. Wambeke Bought ― shares of NeuroOne Medical Technologies on Mar 03, 2026 for an estimated value of $670.00K.
What is the percentage of profitable transactions made by David J. Wambeke?
The percentage of profitable transactions made by David J. Wambeke is 75%.
What is the average return per transaction made by David J. Wambeke?
The average return per transaction made by David J. Wambeke is 24.00%.
What stocks does David J. Wambeke hold?
David J. Wambeke holds: DMAC, NMTC stocks.
What was David J. Wambeke’s latest transaction?
David J. Wambeke latest transaction was an Informative Buy of $670.00K.
What was David J. Wambeke's most profitable transaction?
David J. Wambeke’s most profitable transaction was an Informative Buy of DMAC stock on November 16, 2023. The return on the trade was 68.40%.
What is David J. Wambeke's role in Diamedica Therapeutics?
David J. Wambeke's role in Diamedica Therapeutics is CBO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.